# Marco Alifano

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marco-alifano/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,240 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 68 |
| i10-index | 221 |
| Last Known Institution | Délégation Paris 5 |
| OpenAlex ID | https://openalex.org/A5054966303 |
| ORCID iD | https://orcid.org/0000-0002-2038-1037 |
| Works | 628 |

## Researcher papers

- [<i>TP53, STK11</i> , and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma](https://scholariq.org/papers/i-tp53-stk11-i-and-i-egfr-i-mutations-predict-tumor-immune-profile-and-the/)
- [Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer](https://scholariq.org/papers/cisplatin-increases-pd-l1-expression-and-optimizes-immune-check-point-blockade/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

## Researcher university

- [Délégation Paris 5](https://scholariq.org/institutions/delegation-paris-5/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.